Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

NK-92 Therapy Is Well Tolerated, Has Minimal Toxicity and Shows Efficacy in a Phase I Trial of Patients with Relapsed/Refractory Hematological Malignancies Relapsing after Autologous Stem Cell Transplantation

Brent Williams, MD PhD, Bertrand Routy, MD, Neal denHollander, PhD, Xing-Hua Wang, MD, Amelie Chaboureau, MSc, Sowmya Viswanathan, PhD, Armand Keating, MD

Blood (2015) 126 (23): 4297.

https://doi.org/10.1182/blood.V126.23.4297.4297

Published: 2015

Journal Articles

Irradiated NK-92 Targets AML Leukemic Stem Cells in Vivo and Gene-Modified CD16+NK-92 Mediates Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Against CD123+ Cells

Brent A. Williams, MD, Xing-Hua Wang, MD, Sonam Maghera, Jeffrey V. Leyton, PhD, Raymond Reilly, PhD, Armand Keating, MD

Blood (2012) 120 (21): 1909.

https://doi.org/10.1182/blood.V120.21.1909.1909

Published: 2012

Journal Articles

NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells

Brent A. Williams, MD, Bishoy Dief, BSc, Xing-Hua Wang, MD, Armand Keating, MD

Blood (2010) 116 (21): 4300.

https://doi.org/10.1182/blood.V116.21.4300.4300

Published: 2010

Journal Articles

Mesenchymal Stromal Cells (MSCs) Acquire Cardiac-Specific Markers but Do Not Become Functional Cardiomyocytes and Retain the Stromal Phenotype.

Robert A. Rose, PhD, Huije Jiang, Phd, Xing Hua Wang, MD, Simone Helke, BsC, James N. Tsoporis, PhD, Nanling Gong, Stephanie C.J. Keating, Thomas G. Parker, MD, Peter Bacx, PhD, Armand Keating, MD

Blood (2007) 110 (11): 1920.

https://doi.org/10.1182/blood.V110.11.1920.1920

Published: 2007

Journal Articles

Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?.

Joerg M. Aswald, MD MSc, Xing-Hua Wang, MD, Sandra Aswald, MD MSc, Loralyn A. Benoit, BSc, Mark Minden, MD PhD, Hans A. Messner, MD PhD, Armand Keating, MD

Blood (2004) 104 (11): 2538.

https://doi.org/10.1182/blood.V104.11.2538.2538

Published: 2004

Journal Articles

Culture Conditions for Generating Human Bone Marrow Stromal Cells Influence Cell Immunophenotype and In Vivo Biodistribution in Immune Deficient Mice.

Joanna Vergidis, BSc, Garnet Suck, MSc, PhD, Xing-Hua Wang, MD, Peter W. Zandstra, BEng, PhD, Armand Keating, MD

Blood (2004) 104 (11): 2334.

https://doi.org/10.1182/blood.V104.11.2334.2334

Published: 2004

NARROW

NK-92 Therapy Is Well Tolerated, Has Minimal Toxicity and Shows Efficacy in a Phase I Trial of Patients with Relapsed/Refractory Hematological Malignancies Relapsing after Autologous Stem Cell Transplantation

Irradiated NK-92 Targets AML Leukemic Stem Cells in Vivo and Gene-Modified CD16+NK-92 Mediates Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Against CD123+ Cells

NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells

Mesenchymal Stromal Cells (MSCs) Acquire Cardiac-Specific Markers but Do Not Become Functional Cardiomyocytes and Retain the Stromal Phenotype.

Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?.

Culture Conditions for Generating Human Bone Marrow Stromal Cells Influence Cell Immunophenotype and In Vivo Biodistribution in Immune Deficient Mice.

Email alerts

ASH Publications

American Society of Hematology

NK-92 Therapy Is Well Tolerated, Has Minimal Toxicity and Shows Efficacy in a Phase I Trial of Patients with Relapsed/Refractory Hematological Malignancies Relapsing after Autologous Stem Cell Transplantation

Irradiated NK-92 Targets AML Leukemic Stem Cells in Vivo and Gene-Modified CD16+NK-92 Mediates Antibody Dependent Cell Mediated Cytotoxicity (ADCC) Against CD123+ Cells

NK-92 Preferentially Targets Acute Myeloid Leukemia Stem Cells

Mesenchymal Stromal Cells (MSCs) Acquire Cardiac-Specific Markers but Do Not Become Functional Cardiomyocytes and Retain the Stromal Phenotype.

Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?.

Culture Conditions for Generating Human Bone Marrow Stromal Cells Influence Cell Immunophenotype and In Vivo Biodistribution in Immune Deficient Mice.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only